Skip to content
Protas logo Protas logo Protas logo
  • What we do
  • Cantata New!
  • Our people
  • News & insights
  • Work at Protas
  • Get in touch Contact Get in touch Contact
Protas logo
  • What we do
  • Cantata
  • Our people
  • News & insights
  • Work at Protas
  • Search
News & Stories

Esther Krofah joins Protas Board of Directors

  • News
June 5, 2023

Share

Protas is delighted to have welcomed Esther Krofah MPP to its Board of Directors.

An image of Esther Krofah on a cream background
Esther Krofah is Executive Vice President of Health for the Milken Institute and a Board Member at Protas

Esther, who joined the board this April, brings to Protas extensive experience in managing efforts to solve critical issues in healthcare and improve patients’ lives through uniting stakeholders and achieving shared goals.

In her current position as Executive Vice President of Health for the Milken Institute, Esther is responsible for the direction of FasterCures, the Centre for Public Health, Feeding Change and the Centre for the Future of Aging.

Prior to this, Esther served as the Director of Public Policy at GlaxoSmithKline and held roles in the United States government and consulting to advance health reform.

She received a BA from Duke University and a Master of Public Policy from Harvard University’s John F Kennedy School of Government.

Lord Prior of Brampton, Chairman of the Board at Protas, said: “Esther is an outstanding addition to the Protas board, bringing many years of expertise in senior and high-profile healthcare initiatives from the US and globally.

“Our central mission at Protas is to reduce the global burden of chronic and infectious disease. Esther’s vast experience in this field will make a major contribution to this. I am delighted to welcome her to the board.”

The Protas Board of Directors has overall responsibility for the direction and management of Protas, working collectively to achieve the organisation’s aims. Its members bring together broad expertise from across clinical, scientific, academic, government and corporate backgrounds.

Esther said: “I am proud to support the work of Protas in building the clinical trial design and execution of the future, as this is a critical component of improving health equity across the biomedical research ecosystem.

“I look forward to advancing collaboration across industries to help break down silos, encourage innovative approaches, leverage areas of expertise, and accelerate action to meet the needs of patients and communities.”

Discover more about our board here.

Protas logo
  • What we do
  • Cantata
  • Our people
  • News & insights
  • Work at Protas
  • Get in touch
  • Engagement with public contributors
  • Website privacy policy
  • Modern slavery statement
  • Terms of use
  • Tenders


© Protas 2025 Managed by Webheads
  • Follow us